Home › Funds › BAKER BROS. ADVISORS LP › GLUE

BAKER BROS. ADVISORS LP position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

BAKER BROS. ADVISORS LP reported holding 4,345,736 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$105.2M, representing 0.55% of its reported portfolio and ranking #25 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed GLUE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.35M sh
Reported value held$105.17M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's GLUE position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in GLUE in Q3 2023 at 4,916,095 shares (US$23.5M). The position peaked in Q2 2026 at 4,345,736 shares, worth US$105.2M. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 4,345,736 shares valued at US$105.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.92M $23.55M New
Q4 2023 4.92M $27.78M Hold
Q1 2024 4.92M $34.66M Hold
Q2 2024 4.92M $18.39M Hold
Q3 2024 4.92M $26.06M Hold
Q4 2024 4.92M $34.12M Hold
Q1 2025 4.92M $22.81M Hold
Q2 2025 4.92M $22.17M Hold
Q3 2025 4.92M $36.43M Hold
Q4 2025 4.35M $68.14M Reduce
Q1 2026 4.35M $71.49M Hold
Q2 2026 4.35M $105.17M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held GLUE?

BAKER BROS. ADVISORS LP has disclosed GLUE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in GLUE?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 4.35M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $105.17M, representing 0.55% of its reported portfolio and ranking #25.

Has BAKER BROS. ADVISORS LP been buying or selling GLUE?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in GLUE. The position peaked in Q2 2026 at 4.35M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.